HTN: Goals of Therapy 2008
Click here to see the explanation of recommendation ratings (Strong, Fair, Weak, Consensus, Insufficient Evidence) and labels (Imperative or Conditional). To see more detail on the evidence from which the following recommendations were drawn, use the hyperlinks in the Supporting Evidence Section below.
HTN: Blood Pressure Treatment Goal
A treatment goal of <140/90 mmHg is recommended for individuals without comorbidities. This level is associated with preventing target organ damage and decreasing cardiovascular risk factors and complications.
HTN: Blood Pressure Treatment Goal for Individuals with Diabetes or Renal Disease
For individuals with hypertension and diabetes or renal disease, a treatment goal of <130/80 mmHg is recommended. These individuals are at an increased risk for cardiovascular and renal morbidity and mortality.
Risks/Harms of Implementing This Recommendation
Conditions of Application
Recommendation 3.2 applies to individuals with diabetes or renal disease.
Potential Costs Associated with Application
Based on the JNC 7 report, the ultimate public health goal of antihypertensive therapy is to reduce cardiovascular and renal morbidity and mortality.
Recommendation Strength Rationale
The ADA Hypertension Expert Work Group concurs with the recommendations from the JNC 7, regarding goals of therapy.
- Updated from The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-46.
- Published in The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA 2003;289:2560-71.
- Risks/Harms of Implementing This Recommendation
The recommendations were created from the evidence analysis on the following questions. To see detail of the evidence analysis, click the blue hyperlinks below (recommendations rated consensus will not have supporting evidence linked).
References not graded in Academy of Nutrition and Dietetics Evidence Analysis Process
The Seventh Report of the Joint National Commitee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure, NIH Publication No. 04-5230, August 2004, produced by the National Heart, Lung and Blood Institute in cooperation with the National High Blood Pressure Education Program.
To access the pdf of the JNC 7, click here: